If longevity research has a favourite organelle, it is the mitochondrion. These tiny structures inside almost every cell turn food into usable energy, and as they wear down with age, so does much of what we associate with ageing: lower energy, poorer recovery, weaker muscle and a slower metabolism. Two peptides target them directly, MOTS-c and SS-31, and they could hardly be more different. Here is how each one works and how far the research has got.
MOTS-c and SS-31 in 60 seconds
- MOTS-c is a peptide your own mitochondria make. It acts as a signal, helping cells use glucose and fat for fuel, especially under stress such as exercise.
- SS-31, also called elamipretide, is a lab-designed peptide that acts as a repair tool, binding to the inner membrane of the mitochondria to help them work efficiently.
- MOTS-c research is mostly in animals so far. SS-31 has been through multiple human trials, and in 2025 it was granted accelerated approval in the United States for Barth syndrome, a rare inherited mitochondrial disease.
Why mitochondria matter
Your mitochondria produce most of the energy your cells run on. They do it with a chain of proteins packed into a folded inner membrane, and they produce some damaging by-products along the way. With age, the number and quality of mitochondria fall, the energy chain becomes less efficient and more of those by-products leak out. Exercise is the most reliable way to build new, healthy mitochondria, which is one reason it does so much for ageing well.
MOTS-c: the signal

MOTS-c is a 16 amino acid peptide encoded in the DNA of the mitochondria themselves, not the cell nucleus. Its discovery in 2015 surprised researchers, because mitochondrial DNA was thought to code only for parts of the energy machinery. Under metabolic stress, MOTS-c travels to the cell nucleus and helps switch on genes involved in using glucose and fat, partly through AMPK, the cell’s energy sensor.
In mice, MOTS-c prevented weight gain and insulin resistance on a high-fat diet. Later work showed that MOTS-c levels rise with exercise in people, and that giving it to older mice improved their physical capacity. That combination is why it gets called an exercise mimetic, and why people researching healthy ageing and metabolism are interested in it. Human trial data is still early, so what we know comes mostly from animal studies.
We stock MOTS-c as Mito Boost (60mg pen) and as a Noventra 10mg pen. It is also one of three ingredients in our Limitless pen, alongside NAD+ and 5-Amino-1MQ.
SS-31: the repair tool
SS-31 is a small, four amino acid peptide designed to get inside cells and concentrate in the inner membrane of the mitochondria. There it binds to cardiolipin, a fat that holds the energy chain’s proteins in place. Damaged cardiolipin means a less efficient chain and more leaking by-products. By stabilising it, SS-31 is thought to help mitochondria produce energy more efficiently and with less collateral damage.
Unlike most peptides in this space, SS-31 has gone a long way in human research. It has been studied in heart failure, in primary mitochondrial myopathy and in Barth syndrome, a rare genetic condition that affects cardiolipin directly. Results were mixed: a large trial in mitochondrial myopathy missed its main goal, while the Barth syndrome work led to an accelerated approval in the United States in 2025. That makes it one of very few compounds in our range with a regulatory approval behind it anywhere, even if for a narrow condition.
How they compare
- Where they come from: MOTS-c is made by the body. SS-31 was designed in a lab.
- What they do: MOTS-c signals the cell to use fuel differently. SS-31 physically supports the machinery that makes energy.
- Evidence: MOTS-c is mostly animal research. SS-31 has several human trials and a narrow approval.
- Why people pair them: one works on how cells use energy, the other on how well they produce it.
Side effects
MOTS-c’s side-effect profile in humans is not well mapped because the human data is limited. In SS-31 trials, the most common side effects were reactions at the injection site, which were usually mild. As with any injectable, sterile technique matters more than anything else.
Frequently asked questions
What is MOTS-c?
MOTS-c is a 16 amino acid peptide encoded in mitochondrial DNA. It helps cells use glucose and fat for fuel under stress, and in animal studies it improved insulin sensitivity and physical capacity.
What is SS-31?
SS-31, also called elamipretide, is a small lab-designed peptide that concentrates in the inner membrane of the mitochondria and binds cardiolipin, helping the energy chain work efficiently.
Is SS-31 approved anywhere?
Elamipretide received accelerated approval in the United States in 2025 for Barth syndrome, a rare inherited mitochondrial disease. It is not approved for general or anti-ageing use, and it is not a registered medicine in South Africa.
Can MOTS-c and SS-31 be used together?
They act at different points, one as a signal for fuel use and one as support for energy production, which is why they are often researched together. No trial has tested the combination.
Sources
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015.
- Reynolds JC et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2021.
- Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology, 2014.
This article is for educational purposes only and is not medical advice. MOTS-c and SS-31 are sold for research use and are not registered medicines in South Africa.
Browsing by goal? See peptides for energy.
For the energy molecule at the centre of all this, read NAD+ vs NMN. For why ageing well is about more than any compound, see healthspan is the number that matters.

